To translate this page | Diese Seite übersetzen | Traduire cette page | Traduci questa pagina | Traducir esta pagina
Use the general translation tool for other languages Click here

"The company is in discussions with a global leader in the healthcare sector to arrange distribution following our regulatory approval," says Stephen J. Browand, CEO BioNeutral Group. "Our healthcare market alone is very broad and includes every hospital, nursing home, home health care patient, every immune suppressed patient, emergency room, ambulance, first responder, and doctor, dental, and veterinary office.

Dr Andy Kielbania PhD, BioNeutral's Chief Scientific Officer explains further: "Whether it is the present Swine Flu pandemic or the most difficult to kill dangerous organisms, Bioneutral's technology has given rise to the only family of sporicidal formulations for the hospital/health care sector, industry (including schools) and the home. Performance is unsurpassed, it has a Green environmental profile, is non corrosive, non staining to most fabrics (eg sheets and pillow cases) and can come into contact with skin while remaining sporicidal."

This EPA required AOAC Sporicidal Test utilising spore impregnated knotted suture loops is an extremely difficult test to pass especially when starting with over one million Clostridium Sporogenes spores. The rapid elimination of these health threatening microorganisms at healthcare facilities will reduce the incidents of Hospital Acquired Infections and the associated loss of lives. Many of today's best known industrial disinfectants, including those commonly used in hospitals and healthcare facilities, are unable to pass this test at all or require up to several hours of direct wet contact to pass.

"While many antimicrobials may eliminate easily eradicated bacteria and some viruses, they have no effect on spores and therefore cannot claim to be sporicidal," says the company. "Some which have passed the EPA required test require hours to be effective, while others requires special protective equipment and highly trained professionals to correctly apply them. Further, some require 90 minutes of direct contact to eliminate spores."

A sporicide/sterilant which operates at room temperature with the rapid kill demonstrated by Ygiene Hospital Grade will provide a substantial economic advantage for future users. Ygiene is easy to use and provides a much quicker turn around time for total sterilisation of equipment and facilities. It will reduce the cost of human resources and capital expenditure, decrease turnaround time for surgical procedures and medical facilities thereby maximising precious resources while providing increased safety for staff and patients alike.

E: Stephen J. Browand, President and CEO steve@bioneutralgroup.com
W: www.bioneutralgroup.com